Cadila Strengthens On Successful Completion Of Phase 1 Clinical Trials Of Its H1N1 Vaccine (04-Mar-2010)
Indian-Commodity : Top News : Cadila Strengthens On Successful Completion Of Phase 1 Clinical Trials Of Its H1N1 Vaccine
Cadila Healthcare spurts 0.73% to close at Rs 798 as the company has successfully completed Phase 1 clinical trials of its H1N1 vaccine. The Company has now commenced the Phase II and III of the clinical trials.
The stock hit an intraday high of Rs.803 till now, as against the 52-week high of Rs.806.9.The stock hit a low of Rs.780.05 during the day. The stock had hit a 52-week low of Rs.237.55 on March 9, 2009.
The stock opens at Rs.780.05 at BSE. The total traded volume of the scrip on BSE till now stood at 8535.
Meanwhile today, the BSE Sensex closed lower by -28.31 points, or -0.17% , at 16971.7.
The NSE Nifty fell by -7.85 points, or -0.15% , at 5080.25.
Cadila Healthcare has an equity capital of Rs 68.25 crore as of 2009 Dec. The face value per share is Rs 5. At the current price of Rs 798, the P/E multiple stood at 41.0405811237455 with book Value of 90.32 and P/BV at 8.84.
The total shareholding pattern of the company as on Dec 2009 stood at Promoters- 74.79%, Institutional Investors- 17.47%, General Public- 5.27% and other investors- 2.47%.
Considering the current price of Rs. 798 at 3:57:00 PM , the stock had outperformed the market over the past one month till 04/03/2010 surged 13.36% as compared to the Sensex''s return of 5% and NSE Nifty''s 5 % returns.
Considering the current price of Rs. 798 at 3:57:00 PM , the stock had outperformed the market over the past one quarter till 04/03/2010 surged 22.91% as compared to the Sensex''s return of -0.07% and NSE Nifty''s -0.07 % returns.
Meanwhile, Cadila Healthcare at its meeting held on February 25, 2010 recommended to issue Bonus Equity Shares in the ratio of 1 (One) Equity Share of Rs. 5/- each fully paid-up for every 2 (Two) Equity Shares of Rs. 5/- each held by the shareholders of the Company on the Record Date to be fixed by the Board of Directors / Committee of the Board after the approval of the shareholders at a general meeting.
Cadila Healthcare Ltd has posted a net profit of Rs 1253.20 million for the quarter ended December 31, 2009 where as the same was at Rs 722.40 million for the quarter ended December 31, 2008. Total Income is Rs 6247.20 million for the quarter ended December 31, 2009 where as the same was at Rs 4606.20 million for the quarter ended December 31, 2008.
Top News Today
 Central Bank of India, one of the oldest state-run banks is likely to employ 2,700 people this year to add to the 3,200 recruited last year. This number will be exclusive of the addition in specialized
 Auto major, Mahindra & Mahindra (M&M) is all set to introduce a smaller version of its multi-purpose vehicle Xylo by Diwali this year as it aims to expand its customer base in the country. The company,
 Godrej Properties, Mumbai based real estate developer launched its new residential project Godrej Alpine in Mangalore. It aims to complete 499-apartment Godrej Alpine for occupation in 36 months. Godrej
|
International Stock News
 The US markets ended with mild gains on Wednesday, on reports that Greece had drafted a new financing deal with the European Union and International Monetary Fund. Greek Prime Minister Lucas Papademos
 The US markets rose on Monday, sending the Dow industrials to their highest close since 2008, as Greece's government made progress on measures to secure international aid. Also, a Labor Department report
 The US markets made a mix closing on Thursday, as a drop in jobless claims fueled optimism about the economy and investors looked to the next day's employment report as the next indicator of the economic
|
|
|